NEUROGENE INC

Neurogene insider selling: President‑CFO Christine Mikail’s 10(b)(5)(1) trades show disciplined liquidity, not panic, and how this may affect stock outlook.

Neurogene CFO Christine Mikail sells 4,800 shares under a pre‑approved plan, while the company holds FDA breakthrough status—what this means for investors.